Pheresis Treatment of Bioterrorism-Induced Sepsis

Award Information
Agency:
Department of Health and Human Services
Branch:
N/A
Amount:
$1,011,540.00
Award Year:
2004
Program:
SBIR
Phase:
Phase I
Contract:
1R43AI058528-01
Agency Tracking Number:
AI058528
Solicitation Year:
2004
Solicitation Topic Code:
N/A
Solicitation Number:
PHS2004-2
Small Business Information
HEMOCLEANSE, INC.
3601 SAGAMORE PARKWAY N, STE B, LAFAYETTE, IN, 47904
Hubzone Owned:
N
Socially and Economically Disadvantaged:
N
Woman Owned:
N
Duns:
N/A
Principal Investigator
 STEPHEN Ash
 (765) 742-4813
 SASH@HEMOCLEANSE.COM
Business Contact
 ROBERT TRUITT
Phone: (765) 742-4813
Email: BTRUITT@HEMOCLEANSE.COM
Research Institution
N/A
Abstract
DESCRIPTION (provided by applicant): Victims of bacterial bioterrorism agents such as anthrax, plague, and tularemia die very often because of septicemia and subsequent multiple organ dysfunction syndrome (MODS). Viral bioterrorism agents such as smallpox

* information listed above is at the time of submission.

Agency Micro-sites

US Flag An Official Website of the United States Government